Congenital Heart Disease | CHOP Research Institute
 

Congenital Heart Disease

The primary objective of this study is to collect biospecimens to conduct protein biomarker studies in patients with heart failure requiring advanced therapies such as OHT and VAD.

This pilot study is investigating the feasibility of a prospective biomarker study in the CICU by measuring enrollment of subjects, as well as the looking at outcomes.

Published on
May 6, 2024
The Lynch Lab for Novel Biomedical Optics is building a noninvasive optical neuromonitoring research device to study neurologic injury risk.
Published on
Feb 9, 2024
CHOP researchers test novel system to help patients with severe complication related to congenital heart disease avoid open heart surgery.

The teenage years can be an exciting time for friendships and becoming more independent. Teens may make different choices about their health based on social cues or peer pressure.

The Lynch Lab's primary focus is on the development and use of novel biomedical optical tools to study risk for neurologic injury in children with cardiac diseases.

Published on
Oct 6, 2023
The Advanced Cardiac Therapies Frontier Program will find new solutions for treating heart failure in children.

Dr. Lynch is a physicist specializing in biomedical optics. Her research focuses on the development and use of novel optical imaging devices to improve the way we monitor the brain in vulnerable pediatric patients.

E-mail:
lynchj3 [at] chop.edu
Published on
Aug 4, 2023
Find out how CHOP researchers create a valuable impact on children’s health in the PolicyLab 2023 Impact Report and more in this week’s research news roundup.

We are looking for teens with CHD who are 15 to 19 years old and have a learner's permit or valid driver's license, or interest in obtaining a learner's permit or driver's license and their parent/legal guardian. The study will be conducted remotely.